Ocular Therapeutix, Inc. (OCUL)
10.49
-0.13
(-1.22%)
USD |
NASDAQ |
Sep 11, 16:00
10.69
+0.20
(+1.91%)
After-Hours: 20:00
Ocular Therapeutix Price to Book Value : 4.429 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 4.429 |
| September 10, 2026 | 4.484 |
| September 09, 2026 | 4.843 |
| September 08, 2026 | 4.801 |
| September 04, 2026 | 4.493 |
| September 03, 2026 | 4.493 |
| September 02, 2026 | 4.603 |
| September 01, 2026 | 4.463 |
| August 31, 2026 | 4.429 |
| August 28, 2026 | 4.375 |
| August 27, 2026 | 4.569 |
| August 26, 2026 | 4.548 |
| August 25, 2026 | 4.594 |
| August 24, 2026 | 4.552 |
| August 21, 2026 | 4.679 |
| August 20, 2026 | 4.683 |
| August 19, 2026 | 4.953 |
| August 18, 2026 | 4.649 |
| August 17, 2026 | 4.497 |
| August 14, 2026 | 4.239 |
| August 13, 2026 | 4.265 |
| August 12, 2026 | 4.320 |
| August 11, 2026 | 4.121 |
| August 10, 2026 | 3.902 |
| August 07, 2026 | 3.880 |
| Date | Value |
|---|---|
| August 06, 2026 | 3.690 |
| August 05, 2026 | 3.589 |
| August 04, 2026 | 3.627 |
| August 03, 2026 | 3.547 |
| July 31, 2026 | 3.450 |
| July 30, 2026 | 3.576 |
| July 29, 2026 | 3.53 |
| July 28, 2026 | 3.568 |
| July 27, 2026 | 3.648 |
| July 24, 2026 | 3.591 |
| July 23, 2026 | 3.640 |
| July 22, 2026 | 3.625 |
| July 21, 2026 | 3.771 |
| July 20, 2026 | 3.678 |
| July 17, 2026 | 3.788 |
| July 16, 2026 | 3.87 |
| July 15, 2026 | 4.206 |
| July 14, 2026 | 4.096 |
| July 13, 2026 | 4.172 |
| July 10, 2026 | 4.307 |
| July 09, 2026 | 4.451 |
| July 08, 2026 | 4.337 |
| July 07, 2026 | 4.362 |
| July 06, 2026 | 4.079 |
| July 02, 2026 | 4.070 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| EyePoint, Inc. | 2.160 |
| Merck & Co., Inc. | 8.473 |
| Theravance Biopharma, Inc. | 3.047 |
| LENZ Therapeutics, Inc. | 0.6476 |
| ANI Pharmaceuticals, Inc. | 2.700 |
Price to Book Value Related Metrics
| PS Ratio | 43.12 |
| PEG Ratio | -0.7005 |
| Price | 10.49 |
| Earnings Yield | -13.47% |
| Market Cap | 2.303B |
| PEGY Ratio | -0.7005 |